Abstract
Sequencing of the blaKPC-positive strain Proteus mirabilis AOUC-001 was performed using both the MiSeq and PacBio RS II platforms and yielded a single molecule of 4,272,433 bp, representing the complete chromosome. Genome analysis showed the presence of several acquired resistance determinants, including two copies of blaKPC-2 carried on a fragment of a KPC-producing plasmid previously described in Klebsiella pneumoniae.
GENOME ANNOUNCEMENT
Proteus mirabilis is one of the leading agents of urinary tract infections and can cause a number of different health care-associated infections, including mainly respiratory tract and skin infections, but also bacteremia (1). Due to a decreased susceptibility to imipenem and an intrinsic resistance to polymyxins and tetracyclines (including tigecycline), the acquisition of β-lactam resistance traits by P. mirabilis might seriously limit treatment options. KPC-type carbapenemases have become the most prevalent acquired carbapenemases in Klebsiella pneumoniae in several areas worldwide (2) and have been sporadically detected also in other Enterobacteriaceae and in Gram-negative nonfermenters (3–6). The acquisition of blaKPC by P. mirabilis represents a rare event, and only a few descriptions have been reported to date (7–9). In this report, we announce the first complete genome sequence of a P. mirabilis strain carrying the blaKPC-2 gene.
P. mirabilis AOUC-001 was isolated in 2013 from the blood culture from an inpatient admitted to the Santa Maria Annunziata Hospital (Florence, Italy). A molecular test performed directly on positive blood culture, using the FilmArray platform (Biofire Diagnostics, UT), detected the presence of the blaKPC gene.
Bacterial DNA was subjected to whole-genome sequencing using the MiSeq (Illumina, Inc., CA) and the PacBio RS II (Pacific Biosciences, CA, USA) platforms, which generated 4,643,660 and 1,841,288 reads, respectively. Short and long raw reads were processed with the PBcR hybrid assembly pipeline (10), producing 8 scaffolds (largest scaffold, 1.96 Mb; N50, 1.52 Mb; L50, 2; average G+C content, 39.42%). Genome finishing was achieved by manual inspection of the draft assembly, exploiting PacBio long reads for resolution of large repeats, and using short reads to close small gaps (11). The final de novo assembly generated a single molecule of 4,272,433 bp, with a raw coverage of 260×, representing the complete chromosome of AOUC-001.
A total of 3,853 coding sequences, 83 tRNAs, 22 rRNAs, and 1 type-IE clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) system were identified by the NCBI Prokaryotic Genome Annotation Pipeline (http://www.ncbi.nlm.nih.gov/genome/annotation_prok).
Screening for known virulence determinants (12) revealed the presence of genes associated with adhesion (mannose-resistant/Proteus-like fimbria [MR/P], P. mirabilis fimbria [PMF], and ambient-temperature fimbria [ATF] operons), motility (flgE, fliFL, cheW, and flaD), iron chelation (hmurR2, znuC, and nrp operon), and production of toxic compounds (pta, hpmA, and zapA).
The antimicrobial resistome of AOUC-001, investigated using ResFinder (13), included acquired determinants conferring resistance to aminoglycosides (aadA1, aacA4, armA, and aph(3′)-Ic), chloramphenicol (cat and catA1), trimethoprim (dfrA1), and sulfonamides (sul1). Additionally, four different β-lactamase genes (blaCMY-16, blaTEM-1, blaOXA-9, and blaKPC-2) were detected. Interestingly, the blaKPC-2 gene was present in two copies.
Further analysis revealed that the two blaKPC-2 copies were embedded in two distinct Tn4401a transposons (14), arranged in a tail-to-tail configuration within the chromosome of AOUC-001. The flanking sequences of these transposons resembled the overall architecture of pKPN101-IT (accession no. JX283456), a KPC-encoding plasmid taken from a K. pneumoniae clinical isolate described in Italy in 2012 (15). Overall, this arrangement suggested a possible integration of a pKPN101-IT-like plasmid within the chromosome of AOUC-001, an event that might have been favored by the endemic presence of KPC-producing K. pneumoniae strains sharing the same setting (16).
Nucleotide sequence accession number.
The complete genome of P. mirabilis AOUC-001 has been deposited at NCBI under the GenBank accession no. CP015347.
ACKNOWLEDGMENTS
This study was funded by Wellcome Trust grant number 098051. C.J.B. was supported by the Medical Research Council (grant G1100100/1).
Footnotes
Citation Di Pilato V, Chiarelli A, Boinett CJ, Riccobono E, Harris SR, D’Andrea MM, Thomson NR, Rossolini GM, Giani T. 2016. Complete genome sequence of the first KPC-type carbapenemase-positive Proteus mirabilis strain from a bloodstream infection. Genome Announc 4(3):e00607-16. doi:10.1128/genomeA.00607-16.
REFERENCES
- 1.O’Hara CM, Brenner FW, Miller JM. 2000. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev 13:534–546. doi: 10.1128/CMR.13.4.534-546.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rossolini GM. 2015. Extensively drug-resistant carbapenemase-producing Enterobacteriaceae producing carbapenemases: an emerging challenge for clinicians and healthcare systems. J Intern Med 277:528–531. doi: 10.1111/joim.12350. [DOI] [PubMed] [Google Scholar]
- 3.Hargreaves ML, Shaw KM, Dobbins G, Snippes Vagnone PM, Harper JE, Boxrud D, Lynfield R, Aziz M, Price LB, Silverstein KAT, Danzeisen JL, Youmans B, Case K, Sreevatsan S, Johnson TJ. 2015. Clonal dissemination of Enterobacter cloacae harboring blaKPC-3 in the upper midwestern United States. Antimicrob Agents Chemother 59:7723–7734. doi: 10.1128/AAC.01291-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Robledo IE, Aquino EE, Santé MI, Santana JL, Otero DM, León CF, Vázquez GJ. 2010. Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother 54:1354–1357. doi: 10.1128/AAC.00899-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Villegas M-V, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP, the Colombian Nosocomial Resistance Study Group . 2007. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother 51:1553–1555. doi: 10.1128/AAC.01405-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwaber MJ, Schwartz D, Carmeli Y. 2006. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 50:3098–3101. doi: 10.1128/AAC.00438-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Tibbetts R, Frye JG, Marschall J, Warren D, Dunne W. 2008. Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC β-lactamase in P. mirabilis. J Clin Microbiol 46:3080–3083. doi: 10.1128/JCM.00979-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hu Y-Y, Cai J-C, Zhang R, Zhou H-W, Sun Q, Chen G-X. 2012. Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese hospital. Antimicrob Agents Chemother 56:2278–2282. doi: 10.1128/AAC.05519-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Cabral AB, Maciel MAV, Barros JF, Antunes MM, Lopes ACS. 2015. Detection of blaKPC-2 in Proteus mirabilis in Brazil. Rev Soc Bras Med Trop 48:94–95. doi: 10.1590/0037-8682-0152-2014. [DOI] [PubMed] [Google Scholar]
- 10.Berlin K, Koren S, Chin C-S, Drake JP, Landolin JM, Phillippy AM. 2015. Assembling large genomes with single-molecule sequencing and locality-sensitive hashing. Nat Biotechnol 33:623–630. doi: 10.1038/nbt.3238. [DOI] [PubMed] [Google Scholar]
- 11.Boetzer M, Pirovano W. 2012. Toward almost closed genomes with GapFiller. Genome Biol 13:R56. doi: 10.1186/gb-2012-13-6-r56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Armbruster CE, Mobley HLT. 2012. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Microbiol 10:743–754. doi: 10.1038/nrmicro2890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644. doi: 10.1093/jac/dks261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Cuzon G, Naas T, Truong H, Villegas MV, Wisell KT, Carmeli Y, Gales AC, Venezia SN, Quinn JP, Nordmann P. 2010. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis 16:1349–1356. doi: 10.3201/eid1609.091389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Frasson I, Lavezzo E, Franchin E, Toppo S, Barzon L, Cavallaro A, Richter SN, Palù G. 2012. Antimicrobial treatment and containment measures for an extremely drug-resistant Klebsiella pneumoniae ST101 isolate carrying pKPN101-IT, a novel fully sequenced blaKPC-2 plasmid. J Clin Microbiol 50:3768–3772. doi: 10.1128/JCM.01892-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Giani T, Arena F, Vaggelli G, Conte V, Chiarelli A, Henrici De Angelis L, Fornaini R, Grazzini M, Niccolini F, Pecile P, Rossolini GM. 2015. Large nosocomial outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae traced to clonal expansion of an mgrB deletion mutant. J Clin Microbiol 53:3341–3344. doi: 10.1128/JCM.01017-15. [DOI] [PMC free article] [PubMed] [Google Scholar]